Digest Network Come funziona
Network
/
Società
Di
Non verificato

Dispatch Bio

Di cosa scriviamo

BiotecnologiaIndustriaOncologiaSaluteScienza

7 comunicati stampa

Guarda tutti i comunicati
12/01/2026
Multimedialità
Telefonia e Varie
Industria
Biotecnologia
Salute
Scienza
Oncologia
Dispatch Bio and CARsgen Announce Clinical Collaboration to Evaluate Flare Platform and Zevor-cel in Solid Tumors
Fonte
Dispatch Bio
Emittente
Business Wire
1.00
0
12/01/2026
Industria
Scienza
Biotecnologia
Oncologia
Salute
Igiene alimentare
Medicina - Varie
Dispatch Bio Announces FDA Clearance of IND Application for DISP-10, a First-in-Class Immunotherapy Treatment, in Solid Tumors
Fonte
Dispatch Bio
Emittente
Business Wire
1.00
0
04/11/2025
Oncologia
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Eventi
Mercato del lavoro
Dispatch Bio Unveils First Clinical Program and Presents Data Supporting Flare Platform at Society for Immunotherapy of Cancer (SITC) 2025 Annual Meeting
Fonte
Dispatch Bio
Emittente
Business Wire
1.00
0
04/11/2025
Mercato del lavoro
Eventi
Industria
Oncologia
Salute
Medicina - Varie
Scienza
Biotecnologia
Dispatch Bio Announces Clinical Supply and Collaboration Agreement with Bristol Myers Squibb in Solid Tumors
Fonte
Dispatch Bio
Emittente
Business Wire
1.00
0
03/10/2025
Biotecnologia
Salute
Oncologia
Eventi
Industria
Dispatch Bio Announces Upcoming Presentations at Society for Immunotherapy of Cancer (SITC) 2025 Annual Meeting
Fonte
Dispatch Bio
Emittente
Business Wire
1.00
0
30/09/2025
Oncologia
Salute
Scienza
Medicina - Varie
Biotecnologia
Mercato del lavoro
Dispatch Bio Appoints Mauro Avanzi, M.D., Ph.D., as Chief Medical Officer
Fonte
Dispatch Bio
Emittente
Business Wire
1.00
0
23/07/2025
Oncologia
Salute
Scienza
Biotecnologia
Industria
Dispatch Bio Launches to Deliver Universal Treatment Across Solid Tumors with Novel Immunotherapy Approach
Fonte
Dispatch Bio
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0